Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 439461, 5 pages
http://dx.doi.org/10.1155/2014/439461
Research Article

Cytotoxicity of Doxycycline Effluent Generated by the Fenton Process

1Department of Biochemical and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of São Paulo, Bloco 16, Avenida Prof. Lineu Prestes 580, 05508-900 São Paulo, SP, Brazil
2Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, University Town Zeferino Vaz, Rua Monteiro Lobato 255, 13083-862 Campinas, SP, Brazil
3Department of Civil, Chemical and Environmental Engineering, Pole of Chemical Engineering, Genoa University, Via Opera Pia 15, 16145 Genoa, Italy

Received 30 July 2014; Accepted 3 September 2014; Published 14 October 2014

Academic Editor: Ricardo P. de Souza Oliveira

Copyright © 2014 Alexandre Augusto Borghi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Ghosh, T. Okuda, N. Yamashita, and H. Tanaka, “Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation,” Water Science and Technology, vol. 59, no. 4, pp. 779–786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jia, Y. Xiao, J. Hu, M. Asami, and S. Kunikane, “Simultaneous determination of tetracyclines and their degradation products in environmental waters by liquid chromatography-electrospray tandem mass spectrometry,” Journal of Chromatography A, vol. 1216, no. 22, pp. 4655–4662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Fatta-Kassinos, M. I. Vasquez, and K. Kümmerer, “Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes—degradation, elucidation of byproducts and assessment of their biological potency,” Chemosphere, vol. 85, no. 5, pp. 693–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. P. Gujarathi, B. J. Haney, and J. C. Linden, “Phytoremediation potential of Myriophyllum aquaticum and Pistia stratiotes to modify antibiotic growth promoters, tetracycline, and oxytetracycline, in aqueous wastewater systems,” International Journal of Phytoremediation, vol. 7, no. 2, pp. 99–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Jiao, S. Zheng, D. Yin, L. Wang, and L. Chen, “Aqueous photolysis of tetracycline and toxicity of photolytic products to luminescent bacteria,” Chemosphere, vol. 73, no. 3, pp. 377–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Yuan, C. Hu, X. Hu, D. Wei, Y. Chen, and J. Qu, “Photodegradation and toxicity changes of antibiotics in UV and UV/H2O2 process,” Journal of Hazardous Materials, vol. 185, no. 2-3, pp. 1256–1263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. V. M. Mboula, V. Héquet, Y. Gru, R. Colin, and Y. Andrès, “Assessment of the efficiency of photocatalysis on tetracycline biodegradation,” Journal of Hazardous Materials, vol. 209-210, pp. 355–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. N. Sturm, “Biodegradability of nonionic surfactants: screening test for predicting rate and ultimate biodegradation,” Journal of the American Oil Chemists' Society, vol. 50, no. 5, pp. 159–167, 1973. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Stavrakakis, V. Hequet, C. Faur, Y. Andres, P. Le Cloirec, and R. Colin, “Biodegradation of endocrine disrupters: case of 17β-estradiol and bisphenol A,” Environmental Technology, vol. 29, no. 3, pp. 269–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Borghi and M. S. A. Palma, “Tetracycline: production, waste treatment and environmental impact assessment,” Brazilian Journal of Pharmaceutical Sciences, vol. 50, pp. 25–40, 2014. View at Publisher · View at Google Scholar
  11. J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, Goodman& Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, NY, USA, 9th edition, 2001.
  12. S. Skúlason, E. Ingólfsson, and T. Kristmundsdóttir, “Development of a simple HPLC method for separation of doxycycline and its degradation products,” Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 4, pp. 667–672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. A. Cunha, “New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited,” Medical Clinics of North America, vol. 90, no. 6, pp. 1089–1107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. S. Aga, Fate of Pharmaceuticals in the Environment and in Water Treatment Systems, CRC Press, Taylor and Francis Books, Boca Raton, Fla, USA, 2008.
  15. E. Neyens and J. Baeyens, “A review of classic Fenton's peroxidation as an advanced oxidation technique,” Journal of Hazardous Materials, vol. 98, no. 1–3, pp. 33–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Pignatello, E. Oliveros, and A. Mackay, “Advanced oxidation processes for organic contaminant destruction based on the Fenton reaction and related chemistry,” Critical Reviews in Environmental Science and Technology, vol. 36, no. 1, pp. 1–84, 2006. View at Google Scholar
  17. S. M. Kumar, “Degradation and mineralization, of organic contaminants by Fenton and photo-Fenton processes: review of mechanisms and effects of organic and inorganic additives,” Research Journal of Chemistry and Environment, vol. 15, pp. 96–112, 2011. View at Google Scholar
  18. Clinical and Laboratory Standard Institute and National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved standards M07-A9, Clinical and Laboratory Standard Institute, Wayne, Pa, USA, 9th edition, 2014.
  19. ISO 10993-5, “Biological evaluation of medical devices—part 5: tests for in vitro cytotoxicity,” in In Vitro Methods, International Organization for Standardization, pp. 24–28, Geneva, Switzerland, 1999. View at Google Scholar
  20. FDA, Doryx (Doxycycline Hyclate) Capsule, Delayed Release Pellets, U.S. Food and Drug Administration, 2013, http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050582s027lbl.pdf.